Silence Therapeutics (SLN) Revenue & Revenue Breakdown
Silence Therapeutics Revenue Highlights
Latest Revenue (Y)
$559.00K
Latest Revenue (Q)
$224.00K
Main Segment (Y)
Research Collaboration Income
Main Geography (Y)
GERMANY
Silence Therapeutics Revenue by Period
Silence Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $559.00K | -98.71% |
| 2024-12-31 | $43.26M | 70.47% |
| 2023-12-31 | $25.38M | 17.18% |
| 2022-12-31 | $21.66M | 74.43% |
| 2021-12-31 | $12.41M | 126.59% |
| 2020-12-31 | $5.48M | 2145.49% |
| 2019-12-31 | $244.00K | 100.00% |
| 2018-12-31 | - | -100.00% |
| 2017-12-31 | $16.00K | -97.92% |
| 2016-12-31 | $770.00K | 100.00% |
| 2015-12-31 | - | -100.00% |
| 2014-12-31 | $15.00K | -87.18% |
| 2013-12-31 | $117.00K | -28.22% |
| 2012-12-31 | $163.00K | -76.51% |
| 2011-12-31 | $694.00K | -70.67% |
| 2010-12-31 | $2.37M | 37.32% |
| 2009-12-31 | $1.72M | -22.00% |
| 2008-12-31 | $2.21M | -45.42% |
| 2007-12-31 | $4.05M | 107.86% |
| 2006-12-31 | $1.95M | 282.51% |
| 2005-12-31 | $509.00K | 220.13% |
| 2004-12-31 | $159.00K | -88.17% |
| 2003-12-31 | $1.34M | 16.77% |
| 2002-12-31 | $1.15M | 734.06% |
| 2001-12-31 | $138.00K | -85.61% |
| 2000-12-31 | $959.00K | -30.00% |
| 1999-12-31 | $1.37M | 552.38% |
| 1998-12-31 | $210.00K | 100.00% |
| 1997-12-31 | - | 100.00% |
| 1996-12-31 | - | 100.00% |
| 1995-12-31 | - | - |
Silence Therapeutics generated $559.00K in revenue during NA 2025, up -98.71% compared to the previous quarter, and up 10.20% compared to the same period a year ago.
Silence Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $224.00K | 57.75% |
| 2025-03-31 | $142.00K | -99.42% |
| 2024-12-31 | $24.33M | 2030.28% |
| 2024-09-30 | $1.14M | 90.97% |
| 2024-06-30 | $598.00K | -95.18% |
| 2024-03-31 | $12.41M | 491.04% |
| 2023-12-31 | $2.10M | -24.98% |
| 2023-09-30 | $2.80M | -69.27% |
| 2023-06-30 | $9.10M | -19.96% |
| 2023-03-31 | $11.37M | 138.70% |
| 2022-12-31 | $4.76M | 41.35% |
| 2022-09-30 | $3.37M | -7.47% |
| 2022-06-30 | $3.64M | -36.33% |
| 2022-03-31 | $5.72M | 67.60% |
| 2021-12-31 | $3.41M | 8.17% |
| 2021-09-30 | $3.16M | 16.85% |
| 2021-06-30 | $2.70M | -14.09% |
| 2021-03-31 | $3.14M | -473.40% |
| 2020-12-31 | $-842.00K | -142.35% |
| 2020-09-30 | $1.99M | 246.95% |
| 2020-06-30 | $573.00K | - |
| 2020-03-31 | $573.00K | 369.67% |
| 2019-12-31 | $122.00K | - |
| 2019-09-30 | $122.00K | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | - |
Silence Therapeutics generated $224.00K in revenue during Q2 2025, up 57.75% compared to the previous quarter, and up 1.81% compared to the same period a year ago.
Silence Therapeutics Revenue Breakdown
Silence Therapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Research Collaboration Income | $559.00K | $43.10M | $24.80M | $16.90M | $12.02M |
| Royalty Income | - | $100.00K | $600.00K | $600.00K | - |
Silence Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 25: Research Collaboration Income (100.00%).
Quarterly Revenue by Product
| Product/Service | Dec 25 | Jun 25 | Mar 25 |
|---|---|---|---|
| Research Collaboration Income | $235.00K | $224.00K | $100.00K |
Silence Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Research Collaboration Income (100.00%).
Silence Therapeutics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|
| GERMANY | $144.00K | $569.00K | $578.00K | $392.00K |
Silence Therapeutics's latest annual revenue breakdown by geography, as of Dec 24: GERMANY (100.00%).
Silence Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AMRN | Amarin | $182.75M | $48.56M |
| CAPR | Capricor Therapeutics | $22.27M | - |
| ACIU | AC Immune | $14.80M | - |
| SLN | Silence Therapeutics | $559.00K | $224.00K |
| LYEL | Lyell Immunopharma | $36.00K | $15.00K |
| ALDX | Aldeyra Therapeutics | - | - |
| KYTX | Kyverna Therapeutics | - | - |
| CTNM | Contineum Therapeutics, Inc. Class A | - | - |
| LXEO | Lexeo Therapeutics | - | - |
| ANRO | Alto Neuroscience | - | - |
| MREO | Mereo BioPharma Group | - | - |